In kurzer und anschaulicher Weise gibt Thomas Binz einen UEberblick uber die biologische Sicherheit im Laborbereich. Die wichtigsten Elemente, wie die Zuteilung der Mikroorganismen zu Risikogruppen, die Bewertung der Risiken bei der Erzeugung von genetisch veranderten Mikroorganismen und die Elemente des Laboratoriums, die im Hinblick auf die biologische Sicherheit besonders relevant sind, werden unter Berucksichtigung der europaischen gesetzlichen Grundlagen dargestellt. Aufgrund des hohen Stellenwerts der Risikobewertung wird detailliert auf dieses Verfahren einschliesslich anschaulicher Beispiele eingegangen. Das Buch soll nicht nur einen UEberblick uber die biologische Sicherheit geben, sondern auch zu ihrem Verstandnis beitragen.Der Autor Dr. Thomas Binz geht einer behoerdlichen Tatigkeit im Bereich Biologische Sicherheit nach (Bewilligungswesen, Abschatzung biologischer Risiken gentechnisch veranderter Organismen, nationale und internationale Rechtssetzung, Biowaffenkonvention). Er ist in verschiedenen nationalen und internationalen Ausbildungsprogrammen (Schweizerisches Biosafety Curriculum, Europaische Gesellschaft fur Biosicherheit) eingebunden und unterrichtet im Rahmen des franzoesischen 'Diplome universitaire' fur Biosicherheit der Universitat Lille.

This volume provides the essential theory as well as practice for the study of urine and body fluids other than urine. It is a concise compendium of information both of a practical as well as a clinical resource for understanding conditions of patients with whom the laboratory analyst has contact. It informs the reader not only of the how to perform certain tests but also of the why these tests are clinically important and therefore helps in obtaining the best clinical data possible.

This text is a review of molecular immunohematology (MI). It draws from analyses and case studies around the world and details many techniques used in many labs. It is aimed at anyone interested in how MI is changing blood bank and transfusion medicine.

Genetically-engineered mouse models for cancer research have become invaluable tools for studying cancer biology and evaluating novel therapeutic approaches. This volume focuses on state-of-the-art methods for generating, analyzing and validating such models for studying aspects of human cancer biology. Additionally, these models are emerging as important pre-clinical systems in which to test cancer prevention and therapeutic strategies in order to select compounds for testing in clinical trials.

Breast cancer remains a disease of considerable public health importance worldwide, with over 800,000 new cases diagnosed globally each year. Considerable energy is currently being spent by researchers to further our understanding of this complex disease, however, keeping up with all of the new data is a real challenge given the sheer volume of information that becomes available on a daily basis. The purpose of this book would be to provide a comprehensive review of breast cancer epidemiology, covering the topics of disease burden, etiology, risk factors, prevention, early detection/screening, treatment, and outcomes. The book would be a single comprehensive source of the most recent information on breast cancer epidemiology, and it would serve as a valuable resource for breast cancer researchers across disciplines regardless of what stage of their career they are in. To the knowledge of the editor, no such resource is currently available.

Point of care testing (POCT) is a new concept in laboratory medicine that is widely used at present. It is the new advent that helps ease medical care in the present day. The knowledge on the POCT medicine is very important and necessary for the general practitioner. In this specific book, the author summarizes, presents and discusses on the concept of POCT, its importance and examples of important POCT tools.

A Guide to Technical Consulting for the Clinical Laboratory offers consulting guidance to provide regulatory instruction to qualified individuals, especially medical technologists who want to pursue a career as a technical consultant for a clinical laboratory. Cathy Manske has more than 40 years' experience working in the field of medical technology as a laboratorian, researcher, and consultant. A Wisconsin transplant to Arizona, she was educated at the University of Wisconsin-Milwaukee, receiving a B.S. in medical technology. Her early work experience was as a generalist in hospitals, and then specializing in microbiology and virology, ultimately becoming a technical consultant to physicians whose offices implemented in-house clinical laboratories. In 2003, she created and incorporated Clinical Laboratory Consultants, Ltd. Since then, she has helped set up more than 60 physicians' office laboratories of varying specialties including pediatric, cardiac, internal, rheumatoid, OBGYN, oncology, endocrinology, urology, and family practice. She also set up six reference laboratories. In addition to starting up clinical labs, she consults with over 20 laboratories in an ongoing technical consultant capacity, and occasionally serving as laboratory director. She successfully guides her clients to full CLIA compliance, while ensuring both accurate testing analysis and profitability. Beyond her thorough knowledge of standard lab practices and prevailing state and federal regulations, the author's strength lies in communicating effectively with CLIA inspectors, doctors, administrators, and laboratory staff. Cathy L. Manske hopes her book will encourage more medical technologists and qualified professionals to pursue the field of laboratory technical consulting. This is her first book. Publisher's website: http: //sbprabooks.com/CathyLManske

This book will enable the production of reliable, accurate, reproducible (best possible care) results that satisfies the customer's requirements obtained from an accredited, process oriented, health and safety conscious laboratory that is cost effectively run (value for money) by qualified, certified and highly motivated biomedical staff (Joy and pride at work) using well maintained, validated and quality controlled equipments and appropriately stored reagents on the right sample drawn from the right patient that is appropriately communicated in a timely fashion to the requesting clinician to enable them render the best possible evidenced- based medical care to their patients.

Written in a very simple and reader-friendly manner, this book can be used by laboratory personnel in the biological and chemical sciences. It addresses the difficulties students and scientific laboratory personnel have with translating chemical concepts into an in-lab practical preparation and description of solutions. Its step-by-step approach in describing pre-laboratory calculations and setups, and the preparation of solution at the bench, was designed to meet the needs of a wide range of laboratory personnel irrespective of their academic status. The provision of alternative methods and approaches presented in this book ensures that readers can choose an approach more suited to their needs and understanding.

This book presents topical research in the study of the procedures, types and complications of biopsies. Topics included in this compilation are the historical evolution of the sentinel node biopsy; temporal artery biopsy; the value of FDG PET/CT in guiding bone marrow biopsy procedures in the initial evaluation of lymphoma patients; biopsy procedures in the diagnosis of IgG4-related sclerosing cholangitis; the options and techniques in the biopsy of musculoskeletal tumours; computed-tomography guided percutaneous biopsy; and lymphatic mapping and sentinel lymph node biopsy in early-stage cervical cancer.

Weareenteringintoaneraofre-awakeningoftheimportanceandinterestinthe role ofaltered intermediary metabolisminthedevelopmentandprogressionof malignancy. Therefore, thisbookMitochondriaandCanceristimelyandrelevant tocontemporaryandfutureresearch, training, andeducation. Thehallmarkstudies ofOttoWarburgetal. (1926)sparkedtheeraoftumorcellmetabolism. Fromthen untilaround1980, studiesofintermediarymetabolismofnormalandmalignant cellsweremajorareasofresearchandofgraduateandpostgraduatetrainingin biomedicalsciences. Thisperiodwasdominatedbymitochondrialstudiesandby thoseextraordinaryoutstandingscientistswhowereaffectionatelyreferredtoasthe "mitochondriacs." However, theadvent, development, andsubsequentdominance ofmoleculargenetics/molecularbiologyandmoleculartechnologyinbiomedical researchwereaccompaniedbythenearlycompletesubmersionofinterestinareas ofintermediarymetabolismandtumorcellmetabolism. Forthepast30orsoyears, graduateandpostgraduatetraining, experienceandfocusinbiochemistry, meta- lism, enzymology, cellphysiologyhavedeclined, beingdisplacedbythedo- nanceofmoleculartechnologies. Therecentrevelationsandadvancesinmolecular genetics/molecularbiologyandthedevelopmentofmolecularandnanotechnology providenewdimensionstoapplytotheunderstandingandelucidationoftheroleof intermediarymetabolismandmitochondrialfunctioninthedevelopmentandp- gressionofcancers. Toaddresstheissuesoftumormetabolism, thepresentand futuregenerationsofresearchersmustintegratetheknowledgeandmethods of biochemistrywiththeknowledgeandtechnologyofmolecularbiology. Thefocusonmitochondriaiscentraltodiscussionsandissuesofintermediary metabolism. Thegenetictransformationofnormalfunctionalcellstoneoplastic cellsimposestheneedforalterationsinintermediarymetabolismandmitochond- alfunctiontoprovidethebioenergetic/synthetic/growthrequirementsforthep- gression of the neoplastic cell to malignancy. In the absence of the metabolic transformation, theneoplasticmalignantcellwillnotachieveitsmalignantpot- tial. Thus, itiscriticaltoestablishtheroleofthemitochondriainthemalignant process. Moreover, speci?calterationsindifferentcancertypesmustbeidenti?ed. Such information will provide new approaches to the treatment and perhaps preventionofdifferingcancers. TheadventofMetabolomicsforthedetectionof v vi Preface cancer and progression of malignancy is dependent upon the elucidation and identi?cationofalteredmetabolismandmitochondrialfunction. Thus, thisexciting journeyincancerresearchhasbarelybegunandhasalongwaytogo. Thisbook, Mitochondria and Cancer, and its subject matter provide a roadmap and the preparationtoproceedonthisjourney. Wearegreatlyindebtedtothecontributingauthorsfortheirenthusiasticsupport andwritingachapterintheirareaofexpertise. WearegratefultoMs. DonnaOvak for secretarial help and our families for their patience and support in putting togetherthisbook. Thisbookisdedicatedtopast, present, andfuture"mitoch- driacs"aroundtheworld. Buffalo, NY KeshavK. Singh Baltimore, MD LeslieC. Costello Contents MitochondriaandCancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 KjerstinM. Owens, J. S. Modica-Napolitano, andKeshavK. Singh WarburgandhisLegacy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 23 MichaelRistowandTimJ. Schulz TheLipogenicSwitchinCancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 KoenBrusselmansandJohannesV. Swinnen CitrateMetabolisminProstateandOtherCancers . .